[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Precision Peptide Company Inc (PNGAF)

Precision Peptide Company Inc (PNGAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
The Precision Peptide Company (BPC) Lead Product Achieves 95.5% Purity in Independent Lab Testing, Clearing the Industry Benchmark and Advancing Toward Commercial Launch

HighlightsThe BPC-157 patch is a wearable, needle-free product, designed to remove the injection barrier that has historically limited consumer adoption of peptide productsResults support The Precision...

BPC.CN : 0.4450 (+5.95%)
PNGAF : 0.3280 (+6.67%)
The Precision Peptide Company's Chief Scientific Officer Justin Kirkland to Be Featured on The Human Upgrade with Dave Asprey

Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide...

BPC.CN : 0.4450 (+5.95%)
PNGAF : 0.3280 (+6.67%)
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates

EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:PFE),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END

BPC.CN : 0.4450 (+5.95%)
PNGAF : 0.3280 (+6.67%)
NVO : 45.07 (+1.78%)
HIMS : 23.04 (+2.67%)
LLY : 1,018.87 (-0.25%)
PFE : 25.79 (+0.51%)
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary -- Investor interest in the next-generation wellness market is picking up fast as peptide-based health and performance...

BPC.CN : 0.4450 (+5.95%)
PNGAF : 0.3280 (+6.67%)
NVO : 45.07 (+1.78%)
HIMS : 23.04 (+2.67%)
LLY : 1,018.87 (-0.25%)
PFE : 25.79 (+0.51%)
The Precision Peptide Company Inc. Announces Exclusive Strategic Marketing Partnership with Mixed Martial Arts Group Limited

Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide...

BPC.CN : 0.4450 (+5.95%)
PNGAF : 0.3280 (+6.67%)
The Precision Peptide Company Nears Commercial Launch of Needle-Free BPC-157 Patch as Final Testing Advances

First wearable peptide patch designed to expand BPC-157 beyond injectables and establish a multi-product transdermal peptide platform under Amino InnovationsVancouver, British Columbia--(Newsfile Corp....

BPC.CN : 0.4450 (+5.95%)
PNGAF : 0.3280 (+6.67%)
C$1.3 Million in Proceeds Received by The Precision Peptide Company from Warrant Exercises

Vancouver, British Columbia--(Newsfile Corp. - May 5, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") a publicly traded wellness company focused on advanced peptide...

BPC.CN : 0.4450 (+5.95%)
PNGAF : 0.3280 (+6.67%)
The Precision Peptide Company Grants RSUs and Stock Options and Settles Debt

Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide...

BPC.CN : 0.4450 (+5.95%)
PNGAF : 0.3280 (+6.67%)
The Precision Peptide Company Announces Strategic Product Marketing Agreement

Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into a strategic...

BPC.CN : 0.4450 (+5.95%)
PNGAF : 0.3280 (+6.67%)
The Precision Peptide Company Applauds FDA Action Advancing Regulatory Clarity for Peptide Therapies

Vancouver, British Columbia--(Newsfile Corp. - April 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a company focused on the next-generation of peptide-based...

BPC.CN : 0.4450 (+5.95%)
PNGAF : 0.3280 (+6.67%)

Barchart Exclusives

Arm Surges on New $300 Price Target: ARM Stock Is at the ‘Center of the Renaissance’ in CPUs
Arm stock pushes higher as Bernstein initiates coverage with an “outperform” rating. Here’s why analyst David Dai sees ARM shares ripping higher from here as the year unfolds. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.